Home > Insider Trading > Filing (0001209191-20-010541)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1735944	Reshma Kewalramani	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp And Cmo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-02-17	944	$241.50	34,341	No	4	F	Direct
Common Stock	Disposition	2020-02-18	120	$241.71	34,221	No	4	S	Direct
Common Stock	Disposition	2020-02-18	540	$242.62	33,681	No	4	S	Direct
Common Stock	Disposition	2020-02-18	134	$243.76	33,547	No	4	S	Direct
Common Stock	Disposition	2020-02-18	260	$244.94	33,287	No	4	S	Direct
Common Stock	Disposition	2020-02-18	129	$245.75	33,158	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $241.71 (range $241.24 to $242.02).
Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $242.62 (range $242.25 to $243.21).
Open market sales reported on this line occurred at a weighted average price of $243.76 (range $243.25 to $244.08).
Open market sales reported on this line occurred at a weighted average price of $244.94 (range $244.36 to $245.32).
Open market sales reported on this line occurred at a weighted average price of $245.75 (range $245.36 to $245.86).